OMRON Healthcare has secured De Novo authorisation from the US Food and Drug Administration (FDA) for new home blood pressure ...
Adventure Gold [AGLD] recorded a 24-hour trading volume of $1.58 billion, representing a staggering 4105.82% increase in the ...
OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...
In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...
SiPhox Health, with MIT roots, is developing a home blood testing device using a silicon photonic chip, yet to be FDA ...